Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pseudoephedrine sulfate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Fenoldopam |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Ethylnorepinephrine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Levosalbutamol |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Isometheptene mucate (substance) |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Epinephryl borate |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Phenylpropylmethylamine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Mephentermine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Lergotrile |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Bromocriptine mesilate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Isoprenaline sulfate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Etafedrine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Racephedrine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Cyclopentamine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Protokylol |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Amantadine hydrochloride |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Isoetarine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Apomorphine hydrochloride |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Ephedrine sulfate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Methylaminoheptane |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Caramiphen hydrochloride |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Etilefrine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Norfenefrine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Cathine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Methylephedrine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Clorprenaline |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Octopamine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
synephrin |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Pholedrine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Oxymetazoline hydrochloride |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Lisuride maleate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Midodrine (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Alpha adrenergic receptor agonist |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Central alfa-adrenoreceptoragonist |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Dipivefrine (substance) |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Vasokonstriktor |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Pseudoephedrine (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Beta adrenergic receptor agonist |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Product containing alpha-2 adrenergic receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Product containing norepinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Sympathomimetic identification |
Component |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
1 |
Dopaminergic drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Sympathomimetic poisoning NOS |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Adrenaline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Accidental adrenalin poisoning |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Intentional adrenalin poisoning |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
forgiftning med adrenalin, uvist med hvilken hensigt |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Accidental norepinephrine poisoning |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Intentional noradrenaline poisoning |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
forgiftning med norepinephrin, uvist med hvilken hensigt |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Sympathomimetic adverse reaction |
Causative agent |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
1 |
Dopamine adverse reaction |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Xamoterol adverse reaction |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
allergi over for sympatomimetikum |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Allergy to dipivefrin (finding) |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Allergy to dopamine |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Allergy to ephedrine (finding) |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Allergy to oxymetazoline |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Allergy to xamoterol (finding) |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Sympathomimetic overdose |
Causative agent |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
1 |
Xamoterol fumarate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Epinephrine + inotropics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Epinephrine [cardiovascular use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalin 1 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalin 100 µg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalin 1000 µg/ml injektionsvæske, opløsning fyldt pen a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalin 500 µg/ml injektionsvæske, opløsning i fyldt pen a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalin 1 mg/ml injektionsvæske, opløsning, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalin 100 µg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalin 1 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalin 1 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Dopamine in Glucose 800micrograms/mL intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
dopaminhydrochlorid 40 mg/ml koncentrat til infusionsvæske, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
dopaminhydrochlorid 160 mg/ml koncentrat til infusionsvæske, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
dopaminhydrochlorid 40 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
dopaminhydrochlorid 40 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Xamoterol [sympathomimetic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Vasoconstrictor sympathomimetics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
noradrenalinhydrogentartrat 2 mg/ml koncentrat til infusionsvæske, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
noradrenalinhydrogentartrat 2 mg/ml koncentrat til infusionsvæske, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
noradrenalinhydrogentartrat 2 mg/ml koncentrat til infusionsvæske, ampul a 4 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
oxedrintartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Epinephrine [resp] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
inhalator, bronkiedilaterende |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
bronchodilatorer + sedativ |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalin 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Epinephrine 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalin 1:1000 1 mg/ml opløsning til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
forgiftning med levarterenol |
Causative agent |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 0,01 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 0,1 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
neutral adrenalin 0,05 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
neutral adrenalin 0,1 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
neutral adrenalin 0,25 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
neutral adrenalin 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalin 1:10.000 100 µg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Product containing alpha adrenergic receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Noradrenaline product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Adrenaline-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
adrenalin øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
Product containing xamoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|